H. Lundbeck plans to acquire Longboard Pharmaceuticals in a $2.6 billion deal, the companies announced Monday.

智通财经APP获悉，丹麦制药巨头Lundbeck表示将以26亿美元的股权价值收购Longboard Pharmaceuticals ...

Longboard Pharmaceuticals Inc.的股价已达到令人印象深刻的里程碑，创下58.92美元的历史新高。这一峰值反映了投资者信心的显著增强，从公司673.36%的一年涨幅可见一斑。制药行业一直密切关注Longboard ...

周一，尽管目标价从45美元上调至60美元，B.Riley分析师仍将Longboard Pharmaceuticals Inc (NASDAQ:LBPH)的评级从买入下调至中性。这一调整是在Longboard宣布与Lundbeck达成约26亿美元的收购协议后做出的，收购价格相当于每股60美元。这一收购价格较Longboard截至2024年9月30日的30天成交量加权平均股价溢价77%。 Longbo ...

两家公司周一表示，Lundbeck将以每股60美元的现金收购Longboard，较Longboard上周五38.90美元的收盘价溢价54%。此外，两家公司表示，该交易预计于今年年底完成，扣除Longboard现金后的价值约为25亿美元。

Pharmaceutical company Lundbeck will acquire Nasdaq-listed Longboard Pharmaceuticals in a $2.6 billion deal, the two ...

Shares of Longboard Pharmaceuticals Inc. were soaring more than 51% on Monday after the announcement of H. Lundbeck’s $2.6 billion deal to acquire the California-based clinical-stage biopharmaceutical ...

Denmark-based H. Lundbeck A/S on Monday agreed to acquire Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) for $60.00 per share ...

After spying blockbuster potential in Longboard Pharmaceuticals’ epilepsy med, brain disease-focused pharma Lundbeck is ...

The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals in a deal worth $2.6 billion ...

The companies said Lundbeck will acquire all of Longboard's shares for $60 per share, which represents a premium of 54.2% to ...